Caretek Medical
www.caretekmedical.net
seis eis
Investment to date:
£248
Share price:
£3.60

target amount:
£130,000
£50,000
Caretek Medical
Caretek Medical will be a platform with a self-learning, AI system, an App and cloud-based infrastructure. The team includes globally recognised clinical experts in maternity, who are developing a digital assistant to help pregnant women access information tailored to the individual characteristics of their pregnancy
About Caretek Medical

Caretek Medical is creating a platform to meet the needs of both mothers and healthcare professionals.

The platform will be a self-learning, AI system, comprising an App, and cloud-based infrastructure. 

The Caretek Medical pregnancy app will revolutionise the delivery of safe, effective and individualised maternity care,  by empowering and motivating the mothers to maximise their chances of a successful pregnancy. The team includes globally recognised clinical experts in maternity. 

Carerek Medical is hosted by the Women’s Health Academic Centre at St Thomas’ Hospital, part of King’s College London (Head of Department, Professor Lucilla Poston CBE).

Professor Philip Steer, emeritus Professor at Imperial College London, directs the development of the medical algorithms underlying the app and founder Dr Nicholas Morris directs the maternal interface.

The governing board is chaired by Professor Sir Sabaratnam Arulkumaran, past President of the Royal College of Obstetricians and Gynaecologists and past President of FIGO (the International Federation of Gynaecologists and Obstetricians).

MD Terry Hook leads the business team of Garry Hirth, Damon Clark, Bryan Foss and others developing the commercial aspects of the business.  

The Problem

For most women, pregnancy is a wonderful experience, but sometimes pregnancy does not progress according to plan. When this happens, women require immediate and factually correct information relevant to what is going on, and whether anything needs to be done about it. Often, reassurance is all that is needed, but occasionally urgent action is necessary and life-saving.

Busy obstetricians and midwives often have insufficient time to deal with such issues in a timely manner, and failures in care are contributing to a growing litigation crisis. In the UK in 2017-18 more than a billion pounds was paid out in compensation for errors in maternity care, indicating the scale of the problem. 

The Solution

The App and Platform are mother focused, rather than focused on health professionals. It will encourage women not only to store their own pregnancy data but also to compare their progress and care with national and international standards. Key aspects that will be monitored include maternal blood pressure, weight, glucose testing (diabetes), as well as fetal growth and wellbeing. With the mother's permission, the clinician can access (either online or via the App) a dashboard presenting the current risks indicators and an audit trail of information relating to the pregnant woman.

The architecture of the platform allows for the collection of accurate data directly from the user. The algorithms which underline the analysis and interpretation of the data, are unique and result from over 30 years' experience of maternity data collection. The IP will continue to grow as data repositories enable further refinement and addition of algorithms. The IP belongs to Caretek Medical. 

The Markets

The markets are global. Our targets are pregnant women together with the commercial and academic organisations supporting them. 

We are currently negotiating to be on approved supplier lists and will negotiate commercial arrangements for licensing the use of our IP.

Market Strategy

Our marketing strategy for promoting the app is initially based on word of mouth and subsequently on social media. We intend targeting networks for pregnant women (i.e. mumsnet) and women who are planning to become pregnant (pre-conception). We plan a program to access 'end users' based on partnership with distributors and manufacturers of both maternity and childcare products. In addition, there is a traditional B2B sales plan for commercial organizations, medical providers and Academia.




To find out more about this pitch or to ask the Director(s) a question please Join Now or Log in below

Join
Log in


Why join Crowd for Angels?

arrowRegister in minutes

arrowNo fees for Investors

arrowInvest from £25

arrowShares held through a Nominee

Why invest in UK businesses

Discover investment opportunities, support companies you believe in and share their success Take advantage of SEIS/EIS tax relief to minimize your tax and the opportunity to obtain higher interest rates than available on bank deposits.


About Crowd for Angels

Crowd for Angels is a regulated crowdfunding platform that raises funds for companies through the issue of shares (equity) and crowd bonds (debt) to investors. Our goal is to bring innovative and appealing products to investors and to provide funding for companies throughout their growth cycle.

Offer Information
Min Max
Investment Target £50,000 £130,000
Share Price £3.60 £3.60
Shares Offered info 13,889 36,111
Percentage Offered info 4.10% 10.00%
Shares Issued info 325,000
Pre-money Valuation 1,170,000
Share Type Ordinary
Minimum Investment £54.00
Tax Relief Available SEIS & EIS
Sector Consumer Goods
Healthcare & Pharmaceuticals
Internet, Apps & eCommerce
Location London, United Kingdom
Company Number 10154317
Pitch Launched On 03/06/2019
Pitch Closes On 02/08/2019
Accepted Payment Methods
Payment Methods

To read the full Caretek Medical pitch, please join.
It is free, quick and easy.

Join Now

Already registered? Log in

Risk Warning

Investing in small public listed or private companies involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Investing in debt pitches through Crowd for Angels (UK) Limited involves lending to companies and therefore your capital is at risk and interest payments are not guaranteed if the borrower defaults. Crowd for Angels is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own Investment Decisions. You will only be able to invest via Crowd for Angels once you are authorised. Please click here to read the full Risk Warning.

This page has been approved as a Financial Promotion by Crowd for Angels (UK) Limited (Company number: 03064807) , which is authorised and regulated by the Financial Conduct Authority (Reference number: 176508). Investments can only be made on the basis of information provided in the Pitches by the Investee Companies concerned. Crowd for Angels takes no responsibility for this Information or for any recommendations or opinions made by the Investee Companies.

Pitches may contain forward looking statements and financial forecasts or projections. Forecasts are not a reliable indicator of future performance. Crowd For Angels makes no judgement or opinion of the likelihood of targets being achieved. Investments made in companies listed on the Crowd For Angels platform are not covered by the Financial Services Compensation Scheme (FSCS).

The availability of any tax relief, including EIS and SEIS, depends on the individual circumstances of each investor and of the company concerned, and may be subject to change in the future. If you are in any doubt about the availability of any tax reliefs, or the tax treatment of your investment, you should obtain independent tax advice before proceeding with your investment.